Profile data is unavailable for this security.
About the company
JCR Pharmaceuticals Co., Ltd. is a Japan-based company primarily engaged in the pharmaceutical business, as well as the medical and research equipment business. The Company operates in two segments. The Pharmaceutical segment engages in the research, production, purchase and sale of medical drugs and pharmaceutical raw materials. The Medical and Research Equipment segment engages in the purchase and sale of the medical and research equipment.
- Revenue in JPY (TTM)40.21bn
- Net income in JPY4.10bn
- Incorporated1975
- Employees934.00
- LocationJCR Pharmaceuticals Co Ltd3-19, Kasuga-choASHIYA-SHI 659-0021JapanJPN
- Phone+81 797328591
- Websitehttps://www.jcrpharm.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Seikagaku Corp | 36.57bn | 2.20bn | 47.50bn | 988.00 | 20.73 | 0.6104 | 11.98 | 1.30 | 40.32 | 40.32 | 670.36 | 1,369.69 | 0.4558 | 2.01 | 4.65 | 37,018,220.00 | 2.74 | 0.4261 | 2.96 | 0.4678 | 47.46 | 54.18 | 6.01 | 0.9814 | 5.04 | -- | 0.0052 | 465.78 | 8.24 | 4.99 | -2.24 | -0.5224 | 30.28 | 0.00 |
| ASKA Pharmaceutical Holdings Co Ltd | 63.17bn | 7.39bn | 67.45bn | 762.00 | 8.46 | 0.9873 | 6.83 | 1.07 | 260.93 | 260.93 | 2,230.35 | 2,235.47 | 0.7159 | 1.67 | 4.03 | 82,902,890.00 | 8.38 | 4.63 | 10.69 | 5.87 | 49.66 | 46.94 | 11.70 | 6.76 | 1.61 | -- | 0.1154 | 14.86 | 3.94 | 6.12 | 78.03 | 34.04 | -37.89 | 23.36 |
| Katakura Industries Co., Ltd. | 39.01bn | 2.90bn | 72.51bn | 1.04k | 23.44 | 0.8854 | 12.54 | 1.86 | 87.82 | 87.82 | 1,179.69 | 2,325.40 | 0.2783 | 2.21 | 5.10 | 37,506,730.00 | 2.19 | 2.35 | 2.82 | 3.34 | 38.25 | 37.75 | 7.87 | 8.32 | 2.71 | -- | 0.1076 | 18.81 | 16.62 | -2.04 | 8.09 | 18.87 | -7.46 | 10.76 |
| Cuorips Inc | 19.39m | -657.94m | 78.06bn | 59.00 | -- | 13.39 | -- | 4,026.29 | -88.11 | -88.11 | 2.60 | 729.16 | 0.0032 | 1.15 | 10.60 | 328,610.20 | -10.89 | -- | -11.14 | -- | 44.66 | -- | -3,394.40 | -- | 35.37 | -- | 0.00 | -- | -39.65 | -- | -39.84 | -- | -- | -- |
| JCR Pharmaceuticals Co Ltd | 40.21bn | 4.10bn | 86.11bn | 934.00 | 20.32 | 1.50 | 11.26 | 2.14 | 32.68 | 32.68 | 321.38 | 443.47 | 0.4022 | 0.5095 | 3.01 | 43,049,250.00 | 4.14 | 8.66 | 6.03 | 13.46 | 74.31 | 74.51 | 10.28 | 18.24 | 1.08 | 24.78 | 0.3364 | 30.60 | 24.83 | 13.11 | 46.00 | 8.19 | 18.54 | 21.67 |
| Kyorin Pharmaceutical Co Ltd | 120.10bn | 5.53bn | 97.23bn | 2.04k | 15.64 | 0.6648 | 9.82 | 0.8096 | 96.24 | 96.24 | 2,091.35 | 2,263.71 | 0.6815 | 1.31 | 2.83 | 58,813,420.00 | 3.14 | 3.05 | 4.07 | 3.79 | 42.90 | 47.11 | 4.60 | 4.76 | 1.30 | -- | 0.1372 | 67.74 | 5.53 | 1.02 | 12.68 | -4.98 | 7.41 | -7.06 |
| Torii Pharmaceutical Co Ltd | 57.25bn | 5.25bn | 109.87bn | 583.00 | 20.41 | 0.8904 | 19.31 | 1.92 | 186.93 | 186.93 | 2,036.86 | 4,284.47 | 0.4304 | 2.79 | 2.23 | 98,195,540.00 | 3.95 | 6.52 | 4.36 | 7.35 | 44.49 | 49.55 | 9.18 | 17.98 | 5.70 | -- | 0.00 | 24.17 | 11.74 | -2.67 | 4.44 | 28.76 | -20.38 | 20.11 |
| Zeria Pharmaceutical Co Ltd | 78.88bn | 9.03bn | 119.36bn | 1.78k | 10.97 | 1.21 | 7.11 | 1.51 | 204.82 | 204.82 | 1,789.40 | 1,858.72 | 0.5418 | 1.50 | 3.71 | 44,387,400.00 | 6.20 | 3.89 | 9.82 | 6.28 | 73.22 | 71.93 | 11.44 | 7.57 | 0.8393 | -- | 0.3508 | 35.09 | 10.74 | 4.14 | 24.78 | 17.49 | 20.77 | 5.29 |
| Nxera Pharma Co Ltd | 23.34bn | -9.84bn | 119.66bn | 350.00 | -- | 1.73 | -- | 5.13 | -115.16 | -115.16 | 270.92 | 767.28 | 0.1792 | -- | 5.05 | 66,685,720.00 | -7.55 | -0.6588 | -8.18 | -0.7036 | 72.71 | 89.83 | -42.14 | -4.46 | 3.96 | -8.45 | 0.5075 | -- | -18.00 | -- | -1,982.98 | -- | -- | -- |
| Mochida Pharmaceutical Co Ltd | 103.55bn | 4.41bn | 122.90bn | 1.52k | 26.47 | 0.9128 | 16.87 | 1.19 | 123.93 | 123.93 | 2,908.72 | 3,593.56 | 0.6565 | 1.75 | 3.42 | 68,032,190.00 | 2.80 | 4.37 | 3.34 | 5.31 | 50.05 | 52.47 | 4.26 | 6.71 | 3.31 | -- | 0.00 | 45.16 | -0.3641 | -1.26 | -31.61 | -11.63 | 10.91 | -1.21 |
Data as of Sep 20 2024. Currency figures normalised to JCR Pharmaceuticals Co Ltd's reporting currency: Japanese Yen JPY
13.47%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 15 Jul 2024 | 7.09m | 5.47% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 2.84m | 2.19% |
| The Vanguard Group, Inc.as of 04 Sep 2024 | 1.98m | 1.52% |
| Nikko Asset Management Co., Ltd.as of 06 Sep 2024 | 986.80k | 0.76% |
| Daiwa Asset Management Co. Ltd.as of 30 Aug 2024 | 953.20k | 0.74% |
| BlackRock Fund Advisorsas of 05 Sep 2024 | 903.40k | 0.70% |
| Schroder Investment Management Ltd.as of 31 Dec 2023 | 846.90k | 0.65% |
| Asset Management One Co., Ltd.as of 05 Sep 2024 | 667.70k | 0.52% |
| Dimensional Fund Advisors LPas of 05 Sep 2024 | 653.72k | 0.50% |
| Tokio Marine Asset Management Co., Ltd.as of 25 Jan 2024 | 560.70k | 0.43% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
